Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 6Tumor-Agnostic 3Gastrointestinal 3Thoracic 2Genitourinary 2Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Neoplasms 3

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Meditation × Tumor-Agnostic × Clear all
NCT07326800 2026-04-16

MAEva-MCT

Institut de Cancérologie de Lorraine

Phase NA Recruiting
190 enrolled
Tumor-Agnostic

Neoplasms

NCT02170350 2025-04-29

Brief Mindful Meditation Practice in Improving Quality of Life in Patients With Cancer Undergoing Radiation Therapy

Thomas Jefferson University

Phase NA Terminated
17 enrolled
Tumor-Agnostic

Neoplasms

NCT03445572 2020-08-06

Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer

M.D. Anderson Cancer Center

Phase NA Completed
41 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡